Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, May 2026, Jun 2026 and Jul 2026.
- Largest single sale: $3.2M (38,730 shares) of Cytokinetics Inc on Jun 24, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | EVP, Chief Financial Officer | Jun 3, 2024 | Jul 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 1, 2026, Cytokinetics Inc: sold 1,112 shares for $98K, under a disclosed plan; 1,112 shares acquired by exercising options. 1 filing: 1
- Jun 29, 2026, Cytokinetics Inc: sold 3,134 shares for $266K, under a disclosed plan; 3,134 shares acquired by exercising options. 1 filing: 1
- Jun 24, 2026, Cytokinetics Inc: sold 38,730 shares for $3.2M, under a disclosed plan; 38,730 shares acquired by exercising options. 1 filing: 1
- May 5, 2026, Cytokinetics Inc: sold 23,906 shares for $1.8M, under a disclosed plan. 1 filing: 1
- Mar 17, 2026, Cytokinetics Inc: sold 4,935 shares for $307K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.